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DepressionRegulation of hypothalamic–pituitary–adrenocortical (HPA) axis activity by stress is a fundamental sur-
vival mechanism and HPA-dysfunction is implicated in psychiatric disorders. Adverse early life experi-
ences, e.g. poor maternal care, negatively inﬂuence brain development and programs an abnormal
stress response by encoding long-lasting molecular changes, which may extend to the next generation.
How HPA-dysfunction leads to the development of affective disorders is complex, but may involve GABAA
receptors (GABAARs), as they curtail stress-induced HPA axis activation. Of particular interest are endog-
enous neurosteroids that potently modulate the function of GABAARs and exhibit stress-protective prop-
erties. Importantly, neurosteroid levels rise rapidly during acute stress, are perturbed in chronic stress
and are implicated in the behavioural changes associated with early-life adversity. We will appraise
how GABAAR-active neurosteroids may impact on HPA axis development and the orchestration of the
stress-evoked response. The signiﬁcance of these actions will be discussed in the context of stress-
associated mood disorders.
 2014 The Authors. Published by Elsevier Inc. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/3.0/).1. Introduction
1.1. Stress, GABAA receptors and neurosteroids
Stressful experiences engage a co-ordinated neuronal and
hormonal response, orchestrated by the hypothalamic–
pituitary–adrenocortical (HPA) axis via activation of corticotro-
phin releasing factor (CRF)-releasing parvocellular neurones of
the hypothalamic paraventricular nucleus (PVN). The activity of
the PVN is subject to regulation by GABA, the dominant inhibitory
neurotransmitter in the hypothalamus (Decavel and Van den Pol,
1990; Miklos and Kovacs, 2002), which acts primarily via GABAA
receptors (GABAARs). The neurocircuitry regulating the activity of
the PVN is highly complex, comprised of mono- and polysynaptic
inputs from a number of different limbic and forebrain regions.
GABAARs are expressed throughout this circuit where they play
an important role in modulating the functional activity, and
hence output, of these brain regions. Thus, regulation of HPA axis
activity through GABAAR-mediated transmission not only occursat the level of the PVN, but also at multiple levels of the stress
neurocircuitry.
GABAARs possess a pentameric structure formed from multiple
subunits. To date, 19 subunits have been identiﬁed (a1-6, b1-3, c1-
3, d, e, h, p and q1-3), which are divided into subfamilies based
upon their amino acid homology (Olsen and Sieghart, 2008,
2009). These subunits exhibit discrete expression proﬁles, allowing
for the expression of 20–30 different GABAAR isoforms within the
CNS (Fritschy and Brunig, 2003; Olsen and Sieghart, 2008; Hortnagl
et al., 2013; Fritschy and Panzanelli, 2014) with most native recep-
tors comprising two a, two b and a single c, d or e subunit.
Importantly, GABAAR isoforms containing the c subunit are gener-
ally, albeit not exclusively (e.g. a5bc2 isoforms) targeted to syn-
apses where they mediate ‘‘phasic’’ GABAergic transmission,
while d-GABAARs comprise a major class of peri- and extrasynaptic
receptors that mediate a ‘‘tonic’’ (Farrant and Nusser, 2005; Belelli
et al., 2009) and ‘‘spill-over’’ (Herd et al., 2013) form of GABAergic
inhibition. The subunit composition not only determines the regio-
nal and cellular location of GABAARs, but also inﬂuences their bio-
physical and pharmacological proﬁle. For example, incorporation
of the c2 subunit in conjunction with speciﬁc a subunits (a1-3
and a5) conveys benzodiazepine (BDZ) sensitivity (Olsen and
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2014).
Modulation of GABAAR function by endogenous ligands may
provide a physiologically and pathologically relevant mechanism
to regulate GABAAR-associated functions and behaviour. In this
respect, the positive allosteric actions of some endogenously
occurring steroids have been identiﬁed to be of particular physio-
logical and pharmacological signiﬁcance over the course the past 3
decades. Speciﬁcally, following the pioneering discovery of the
GABAAR potentiating actions of the synthetic anaesthetic steroid,
Alphaxalone (5a-pregnan-3a-ol-11,20-dione Harrison and
Simmonds, 1984) certain endogenous steroids, synthesised de novo
in the brain and hence called neurosteroids (Baulieu, 1981) were
shown to share this property. Such neurosteroids include the pro-
gesterone (PROG) metabolites 5a-pregnan-3a-tetrahydroproges-
terone (5a3a-THPROG), 5b-pregnan-3a-tetrahydroprogesterone
(5b3a-THPROG) and the deoxycorticosterone (DOC) metabolite
5a,3a-tetrahydrodeoxycorticosterone (5a3a-THDOC), which in
common potently and stereo-selectively enhance GABAAR function
in an allosteric fashion (Paul and Purdy, 1992; Belelli and Lambert,
2005). Intriguingly, the levels of such neurosteroids are rapidly ele-
vated following acute stress (Purdy et al., 1991; Barbaccia et al.,
2001; Morrow et al., 2009) and therefore, they may act to ‘‘ﬁne-
tune’’ the function of GABAARs and consequently inﬂuence HPA
axis activity. In support, neurosteroids inhibit CRF release and
exhibit anxiolytic and stress-protective properties (Crawley et al.,
1986; Patchev et al., 1994, 1996; Carboni et al., 1996; Bitran
et al., 1999).
Electrophysiological recordings have demonstrated that neu-
rosteroids, such as 5a3a-THPROG and 5a3a-THDOC, potentiate
the response of GABA (i.e. GABA-modulatory) at nanomolar aque-
ous concentrations, whilst at higher concentrations these endoge-
nous regulators directly activate (i.e. GABA-mimetic) the GABAAR-
channel complex (Callachan et al., 1987; Lambert et al., 1995; Shu
et al., 2004). A signiﬁcant body of evidence consistent with the
presence of a speciﬁc neurosteroid binding site on the receptor
has been provided during the past 25 years including: modulation
of [3H] muscimol binding in solubilised preparations with minimal
lipid content (Bureau and Olsen, 1993); clear enantioselectivity
(Wittmer et al., 1996) and antagonism of both the in vitro and
in vivo actions of neurosteroids by selective ligands i.e. 3a5a-17-
phenylandrost-16-en-3-ol (17PA – Mennerick et al., 2004). A more
deﬁnitive validation arose from site-directed mutagenesis studies,
which revealed that neurosteroids interact with two distinct
groups of amino acid residues located within the transmembrane
(TM) domains of the GABAAR, which are both critical for their
GABA-modulatory and the GABA-mimetic actions (Hosie et al.,
2006). Subsequent reports have indicated that the neurosteroid
binding pocket may possess a more complex structure than ini-
tially suggested with additional amino acid residues contributing
to the modulatory actions of distinct, but structurally related ste-
roid molecules (Akk et al., 2008; Chisari et al., 2010; Zorumski
et al., 2013). Note that in vitro electrophysiological studies consis-
tently report neuroactive steroids such as 5a3a to enhance GABAA-
R function at nM aqueous concentrations, suggesting the presence
of a relatively high afﬁnity binding site on the GABAAR protein.
However, by virtue of their high lipid solubility, the actual concen-
tration of neurosteroid achieved locally at the receptor protein will
be in the micromolar range. Indeed, the differential accumulation
of these steroids within the lipid membrane may serve to increase
their local concentration, a suggestion which is in accord with a
putative transmembrane docking site for neurosteroids. Such a
scenario would enable and indeed facilitate neurosteroid access
to a relatively low afﬁnity binding site(s) located within the trans-
membrane spanning regions of the protein, via lateral diffusionthrough the membrane bilayer (Akk et al., 2005; Akk et al., 2007;
Chisari et al., 2010).
A variety of factors have been shown to inﬂuence the apparent
sensitivity of native GABAARs to neurosteroid modulation, includ-
ing the subunit composition, phosphorylation state of the receptor
and local steroid metabolism (Belelli and Lambert, 2005; Lambert
et al., 2009; Nani et al., 2013). A detailed discussion of the relative
contribution by each of these molecular mechanisms can be found
in recent reviews (Herd et al., 2007; Lambert et al., 2009; Gunn
et al., 2011).
Importantly, from a physiological perspective, naturally occur-
ring plasma and brain levels of neurosteroids are estimated to be
within a range required to potentiate GABAAR function. Further,
the synthesis of these neuromodulators is dynamically regulated
in response to physiological and pathophysiological challenges
e.g. stress thus supporting the proposal for a signiﬁcant role as
endogenous regulators of GABAAR-mediated inhibitory transmis-
sion both in the central (CNS) and peripheral nervous system
(PNS). In this review we will speciﬁcally appraise and focus on
the documented and potential relevance of such actions for the
early programming of the stress-neurocircuit and the regulation
of stress-evoked responses. The potential pathological signiﬁcance
of such actions for stress-associated psychopathology will also be
discussed.2. Neurosteroids: endogenous modulators of GABAAR function2.1. Neuronal and glia-mediated synthesis of neurosteroids
Although a signiﬁcant proportion of neurosteroids are derived
from peripheral sources, such as the adrenal cortex and ovaries
(Paul and Purdy, 1992), the brain itself is a steroidogenic organ that
is capable of the de novo synthesis of these neuromodulators
(Purdy et al., 1991; Reddy, 2003; Barbaccia, 2004). Neurosteroids
are synthesised from cholesterol via a series of steps that include
the translocation of cholesterol across the mitochondrial mem-
brane by the steroidogenic acute regulatory protein (StAR) and
translocator protein 18 kDa (TSPO; formerly the mitochondrial
peripheral BDZ receptor), the rate limiting step of steroid and neu-
rosteroid synthesis. Within the mitochondria, cholesterol is con-
verted to pregnenolone (PREG) by the P450 side-chain cleavage
enzyme, CYP11A1 and then trafﬁcked to the cytoplasm where it
can be converted to a number of neurosteroids known to be active
at the GABAAR, including 5a3a-THPROG. PREG is converted to
5a3a-THPROG following three sequential reactions catalysed by
3b-hydroxysteroid dehydrogenase (3b-HSD), 5a-reductase (5a-R)
and 3a-hydroxysteroid dehydrogenase (3a-HSD), with progester-
one and 5a-dihydroprogesterone (5a-DHP) being the respective
intermediates (Do Rego et al., 2009). Two of these enzymes, 5a-R
and 3a-HSD, are also involved in the conversion of the peripherally
derived glucocorticoid metabolite, deoxycorticosterone (DOC) into
5a3a-THDOC (Fig. 1 – Karavolas and Hodges, 1990). Although a
detailed discussion is beyond the scope of this review (but see
Do Rego et al., 2009), two isoforms of 5a-R (type I and II) exist.
While type I is the most abundant in both human and rodent brain,
type II can be hormonally (e.g. testosterone) induced (Torres and
Ortega, 2003).
A variety of brain cells have been shown to synthesise neuros-
teroids. Early studies described a role for astrocytes and glia in
neurosteroidogenesis (Melcangi et al., 1993; Mellon and
Deschepper, 1993). However, more recent immunohistochemical
studies have suggested that the synthetic machinery necessary
for neurosteroidogenesis, including StAR (King et al., 2002),
CYP11A1 (Kimoto et al., 2001), 3a-HSD and 5a-R (Agis-Balboa
Fig. 1. Synaptic and extra-synaptic GABAAR isoforms, neurosteroid synthesising enzymes and 5a3a-reduced pregnane steroids in the stress neurocircuitry. Diagrammatic
representation of a sagittal section of a rodent brain depicting the expression proﬁle of GABAA receptor isoforms, the neurosteroid synthesising enzymes 5a-reductase (5a-R)
and 3a-HSD and the distribution of GABAAR-modulating 5a3a-reduced pregnane steroids (e.g. 5a3a-THPROG), within the stress neurocircuitry. The reported expression of
GABAAR subtypes is derived from both immunohistochemical and electrophysiological studies as referenced below. Note that GABAAR isoforms responsible for mediating
phasic and tonic inhibition are expressed in a neurone-speciﬁc manner throughout the stress neurocircuitry. Note that for simplicity GABAAR isoforms expressed in various
regions of the amygdala are not displayed but a discussion can be found in (Marowsky et al., 2012; Herman et al., 2013). Similarly, 5a-R, 3-HSD and 5a3a-reduced pregnane
steroids have been detected across the stress axis albeit their levels exhibit distinct region-selective expression proﬁle. References for the region-selective expression for the
above enzymes are the following: prefrontal cortex, (PFC; Grobin et al., 2003; Castelli et al., 2013; Mitev et al., 2003); hippocampus, (Saalmann et al., 2007; Agis-Balboa et al.,
2006; Castelli et al., 2013) and amygdaloid nuclei (Saalmann et al., 2007; Castelli et al., 2013; Do Rego et al., 2009; Mitev et al., 2003). The nucleus of the solitary tract (NTS)
and the locus coreleus (LC), which directly innervate the PVN both exhibited immuno-reactivity for the 5a3a-reduced pregnane steroids (Saalmann et al., 2007), while 5a-R
has been reported in LC and in the dorsal raphe (DR) nucleus (Castelli et al., 2013). Both the lateral septum (LS) and the bed nucleus of the solitary tract (BST) show immuno-
reactivity for 5a3a-reduced pregnane steroid, while the relative expression of 5a-R and 3a-HSD remains to be determined. 5a-R expression has been shown in the nucleus
accumbens shell, and to lesser extent in the core, while the presence of 3a-HSD and 5a3a-reduced neurosteroids remains to be determined. The hypothalamus displays an
abundant expression of 5a-R and 3a-HSD abundantly (Li et al., 1997; Gao et al., 2002; Eechaute et al., 1999), although the expression in speciﬁc sub-regions requires further
analysis. Within the PVN speciﬁcally, only the expression of 5a-R has been conﬁrmed (Castelli et al., 2013), while dense 5a3a-reduced pregnane steroid immunoreactivity
has been found in the periventricular zone (Saalmann et al., 2007). See also Section 2.1 and Fig. 2 for additional details. The bottom right panel depicts enzymatic steps that
mediate 5a3a-THPROG synthesis from progesterone and describes the inhibitors of the individual enzymatic steps. (See above-mentioned references for further
information.)
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number of brain regions, including the hippocampus and cortex
(see Fig. 1 for details). Furthermore, immunohistochemical analysis
of 5a3a-reduced pregnane steroid (e.g. 5a3a-THPROG, 5a3a-
THDOC) localization within the brain, has detected the expressiononly in the cell bodies and dendrites of excitatory (glutamatergic)
and, to a lesser extent, inhibitory (GABAergic) neurones in a brain
region speciﬁc manner (e.g. Saalmann et al., 2007). Such observa-
tions are consistent with the proposed paracrine or indeed auto-
crine role of neurosteroids to locally regulate GABAAR-mediated
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2011). Although there is signiﬁcant evidence to suggest a neuronal
synthesis of neurosteroids, it is noteworthy that TSPO, the rate lim-
iting step in steroid and neurosteroid synthesis (Rupprecht et al.,
2010 – see Section 2.2), is highly expressed in glia, microglia and
reactive astrocytes (Gavish et al., 1999; Kuhlmann and Guilarte,
2000; Casellas et al., 2002; Maeda et al., 2007) with only limited
neuronal expression (Anholt et al., 1984; Bolger et al., 1984). Thus,
it seems highly likely that, as originally postulated (Melcangi et al.,
1993), glia are involved, at least to a degree, in the de novo synthe-
sis of neurosteroids from cholesterol.
2.2. Local neurosteroid regulation of GABAAR function: physiological
and pharmacological relevance
Recent experimental evidence provides considerable support to
the notion that locally produced neurosteroids can enhance
GABAergic transmission, and hencemodulate neuronal excitability.
Typically, the effect of these neuromodulators at synaptic and extra-
synaptic GABAARs is manifest as a prolongation of the decay time of
inhibitory post-synaptic currents (IPSCs) and as an increase in the
tonic conductance respectively. Pharmacological manipulation of
brain steroidogenesis has proved a useful strategy in elucidating
the inﬂuence of local neurosteroid production upon shaping inhibi-
tory transmission in speciﬁc neuronal populations. Thus, inhibition
of 5a-reductase activity with the antagonist SKF105111 (11b-17-
[bis(1 methylethyl) amino carbonyl – Fig. 1], resulted in a reduction
in the decay time constant of spontaneous inhibitory post-synaptic
currents (sIPSCs) recorded from neocortical pyramidal cells derived
from the SKF-treated cf saline treated mice, indicating the presence
of an endogenous neurosteroid tone in these neurones (Puia et al.,
2003). In the hippocampus,miniature IPSCs (mIPSCs) recorded from
dentate gyrus granule cells (DGGCs) were more sensitive to prolon-
gation by the metabolically stable synthetic steroid analogue,
ganaxalone (3b-methyl-5a3a-THPROG) in comparison to 5a3a-
THPROG, raising the possibility that neurosteroid metabolism may
be responsible for this differential sensitivity (Belelli and Herd,
2003). In particular, 3a-HSD, unlike 5a-reductase, is involved in
both the synthesis and degradation of 5a3a-THPROG (and 5a3a-
THDOC) as the cytosolic isoform catalyses the reductive formation
of 5a3a-THPROG from 5a-dihydroprogesterone (5a-DHP), whilst
themembrane bound isoform promotes the reverse, oxidative reac-
tion (Li et al., 1997 – Fig. 1). Interestingly, in the dentate gyrus (DG)
themembrane-bound isoform is prevalent and the inhibition of this
enzyme with indomethacin, or methoxyprogesterone acetate (Pro-
vera – Fig. 1) resulted in a modest increase in both the mIPSC decay
time constant and the bicuculline-sensitive tonic conductance,
whereas CA1 GABAAR-mediated transmission remained unaffected
by similar manipulations Furthermore, the treatment of brain slices
with indomethacin or Provera alone enhanced the sensitivity of
DGGCs to exogenously applied 5a3a-THPROG (100 nM, Belelli and
Herd, 2003). Collectively, these observations indicate that the rela-
tive activity of 3a-HSD isoforms can inﬂuence the concentration of
neurosteroids GABAARs experience and hence, may play a crucial
role in shaping inhibitory transmission in a neurone, or even syn-
apse, speciﬁc manner.
As described above, the translocator protein 18 kDa (TSPO) is
located on the outer mitochondrial membrane, and in conjunction
with the steroidogenic acute regulator protein (StAR, Sierra, 2004)
mediates the translocation of cholesterol across the outer mito-
chondrial membrane, the initial, and rate limiting step of steroid
and neurosteroid synthesis (Rupprecht et al., 2010). Thus, provided
a neurone contains the full complement of functionally active ste-
roidogenic enzymes required for the de novo synthesis of 3a-
reduced neurosteroids, then the stimulation of TSPO-mediated
cholesterol translocation should increase the level of neuroster-oids. Indeed, etifoxine is an anxiolytic drug that not only acts as
a positive allosteric modulator of GABAAR function, but also stim-
ulates TSPO to increase the cerebral production of 5a3a-THPROG,
an effect that contributes to the behavioural actions of this drug
(Verleye et al., 2005). More recent studies, in neurones from the
mouse medial prefrontal cortex (mPFC), demonstrated that the
selective TSPO ligand XBD173 (N-benzyl-N-ethyl-2-[7,8-dihydro-
7-methyl-8-oxo-2-phenyl-9H-purin-9-yl] acetamide) produces an
enhancement of the amplitude and duration of evoked IPSCs
(eIPSCs) and mIPSCs. These effects were blocked by the 5a-reduc-
tase inhibitor, ﬁnasteride (Rupprecht et al., 2009). In addition,
XBD173 is effective in rodent behavioural tests predictive of
anxiolytic action, and these actions are attenuated by the TSPO
antagonist PK11195 1-(2-chlorophenyl)-N-methyl-N-(1-methyl-
propyl)-3-isoquinolinecarboxamide; Rupprecht et al., 2009].
Importantly, the anxiolytic actions of XBD173 extend to human
subjects, adding further credence to the proposal that compounds
selectively targeting TSPO may provide novel anxiolytic agents
with a reduced side effect proﬁle (Rupprecht et al., 2009, 2010;
Nothdurfter et al., 2012).
The treatment of brain slices with neurosteroid precursors such
as PROG and DHP, have proved useful in establishing the steroido-
genic potential of speciﬁc neurones. For example, in hippocampal
CA1 pyramidal neurones, the inhibition of 5a-reductase with ﬁnas-
teride had no effect upon the decay time course of mIPSCs.
However, the bath application of the 5a-reductase substrate, PROG
(1 lM) resulted in a slowly developing, and ﬁnasteride-sensitive
prolongation of the mIPSC decay kinetics (Sanna et al., 2004). Such
observations may suggest that although CA1 pyramidal neurones
do not exhibit a constitutive neurosteroid tone, the enzymes
required for neurosteroidogenesis (i.e., 5a-reductase, 3a-HSD)
are functionally expressed within these neurones. However, PROG
had no effect upon the hippocampal expression of the 3a-HSD
gene in either gender thus suggesting the lack of a simple correla-
tion with precursor substrate levels (Mitev et al., 2003). Whilst the
speciﬁc molecular mechanisms regulating enzymes gene expres-
sion and function remain to be fully elucidated, of signiﬁcance, a
recent study in rodent hippocampal CA1 pyramidal neurones has
revealed activation of NMDA receptors (NMDARs) to rapidly pro-
mote neurosteroid synthesis (Tokuda et al., 2011) via a signalling
mechanism involving p38 mitogen-activated protein kinase
(MAPK), neuronal nitric oxide synthase and calcineurin (Izumi
et al., 2008). Thus, NMDARs may play a pivotal role in the regula-
tion of neurosteroidogenesis, potentially linking initial neural exci-
tation to enhancement of neuronal inhibition.
In addition to a physiological role as regulators of GABAergic
transmission, neurosteroids have been implicated in the pharma-
cological actions of a range of structurally diverse drugs acting
on the GABAA receptors. Thus, several line of evidence have impli-
cated neurosteroids in some of the electrophysiological and behav-
ioural effects associated with ethanol administration (VanDoren
et al., 2000; Khisti et al., 2003; Sanna et al., 2004; Morrow et al.,
2006; Izumi et al., 2007; Boyd et al., 2010; Tokuda et al., 2011).
For example, the acute application of ethanol to CA1 pyramidal
neurones promoted synthesis of 5a3a-THPROG resulting in an
augmented peak amplitude and a prolonged decay time course of
the mIPSCs recorded from such neurones (Sanna et al., 2004). Fur-
thermore, in rats, acute ethanol treatment completely blocked the
induction of hippocampal long-term potentiation (LTP), an effect
dependent upon NMDAR-induced neurosteroid synthesis and, in
agreement, sensitive to inhibition by either ﬁnasteride or the
NMDAR antagonist AP-5 (Izumi et al., 2007; Tokuda et al., 2011).
Similarly, the effects of certain clinically important benzodiaze-
pines (BDZs) may be mediated by (i) binding directly to the GABAAR
(at a site between the a and c subunits) to allosterically and
rapidly enhance receptor function and (ii) activating TSPO to
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increasing neurosteroid production. The best characterised BDZs
which exhibit potentially pharmacologically relevant afﬁnity for
TSPO and the GABAAR include diazepam and midazolam, whereas
the potent GABAAR-acting BZD clonazepam is a weak TSPO ligand
(McCauley et al., 1992; Kalk et al., 2013). Evidence that both molec-
ular targets may contribute to the pharmacological actions of such
ligands has been offered by various independent investigations.
Thus, for example, midazolam, a BDZ used clinically to facilitate
the induction of anaesthesia, increased neurosteroid levels in CA1
pyramidal neurones and prevented the induction of LTP, a molec-
ular correlate of memory function, in an acute brain slice prepara-
tion (Tokuda et al., 2010). Implicating neurosteroids, inhibiting
their synthesis with ﬁnasteride, or preventing the GABA-modula-
tory actions of neurosteroids with the selective antagonist 17PA
(Mennerick et al., 2004) attenuated the midazolam-induced
impairment of LTP, consistent with a role for neurosteroidogenesis
in the documented amnestic actions of this BDZ (Tokuda et al.,
2010). In agreement with these in vitro ﬁndings, ﬁnasteride pre-
treatment 1 day prior to midazolam injection, completely abol-
ished the effects of this BDZ upon contextual fear learning
(Tokuda et al., 2010). Similarly, midazolam exhibited a clear anti-
convulsant action in the i.v. PTZ threshold model, which was signif-
icantly attenuated by ﬁnasteride treatment (Dhir and Rogawski,
2012). In contrast, clonazepam, an anxiolytic and anticonvulsant
BDZ, did not induce changes in hippocampal neurosteroid synthe-
sis, and had no effect upon LTP induction. However, consistent
with a role for neurosteroidogenesis in the attenuation of LTP
induction, when administered with the TSPO agonist FGIN (2-[2-
(4-ﬂuorophenyl-1H-indol-3-yl), or together with exogenous
5a3a-THPROG, clonazepam induced similar LTP-impairing effects
to midazolam (Tokuda et al., 2010). However, the clinical relevance
of midazolam actions have been questioned by a recent PET study
suggesting the TSPO occupancy by clinically relevant concentra-
tions of midazolam to be too low to contribute to the BZD in vivo
proﬁle in humans (Kalk et al., 2013). Therefore some caution may
need to be exercised when extrapolating ﬁndings from rodent
studies to humans.3. GABAA receptors and neurosteroids in the stress response3.1. The stress circuitry and a role for GABAARs in the stress response
Maintaining physiological homeostasis in response to environ-
mental and physiological challenges is essential for an organism
to survive and such an ability to adapt is mediated through a num-
ber of tightly regulated and highly conserved interconnected sys-
tems. The hypothalamic paraventricular nucleus (PVN) is a brain
region that is integral in the initiation of the neuroendocrine and
autonomic response to a stressful challenge (Herman and
Cullinan, 1997). Following stressor exposure, spinally projecting
parvocellular neurones (located in dorsal and ventromedial
regions) of the PVN rapidly modulate autonomic function, whilst
neuroendocrine parvocellular neurones (located in dorsomedial
regions), project to the median eminence and initiate activation
of the HPA axis through the release of CRF (Ulrich-Lai and
Herman, 2009). The HPA axis is a neuroendocrine pathway that
couples the CNS to the periphery, and is regulated via hormonal
feedback pathways (e.g. glucocorticoid, CRF) and a complex neuro-
circuitry comprised of mono- and polysynaptic pathways (Herman
et al., 2003; de Kloet et al., 2005; Ulrich-Lai and Herman, 2009). As
noted earlier, GABA has been identiﬁed as the dominant inhibitory
neurotransmitter within the PVN (Decavel and Van den Pol, 1990)
and, in agreement, exerts a signiﬁcant inhibitory tone upon HPA
axis function (Cullinan et al., 2008). Tract tracing studies in rodentshave revealed the majority of the GABAergic afferents to the PVN
to originate from a number of local hypothalamic nuclei (e.g.
peri-PVN, dorsomedial hypothalamus, anterior hypothalamus, pre-
optic area (Roland and Sawchenko, 1993; Herman et al., 2002,
2003) as well as regions of the extended amygdala (e.g. bed
nucleus of the stria terminalis, BST (Cullinan et al., 1993; Dong
et al., 2001c; Dong and Swanson, 2004, 2006) – Fig. 2). Limbic
and forebrain regions (e.g. ventral subiculum, medial prefrontal
cortex and amygdala) also exert signiﬁcant inﬂuence upon HPA
axis activity, but do not directly innervate the PVN (Herman
et al., 2003; Ulrich-Lai and Herman, 2009). Rather, these limbic
and forebrain structures modulate HPA axis function via projec-
tions to a number of the local GABAergic nuclei, in particular
regions of the BST (Dong et al., 2001b; Radley et al., 2009; Radley
and Sawchenko, 2011 – Fig. 2) and peri-PVN (Herman et al.,
2002), which act as neural hubs to integrate and relay limbic and
forebrain inﬂuences upon HPA function to the PVN (Herman
et al., 2002, 2003; Ulrich-Lai and Herman, 2009; Radley, 2012 –
Fig. 2).
The GABAergic inhibitory tone is balanced by a comparable
excitatory input to the PVN, which is heavily innervated by excit-
atory glutamatergic terminals (Decavel and van den Pol, 1992).
Retrograde ﬂuorogold labelling has revealed glutamatergic inputs
to originate from regions of the ventromedial and dorsomedial
hypothalamus (Ulrich-Lai et al., 2011) and to co-exist with local
interneurons within the PVN (Boudaba et al., 1997; Herman
et al., 2002), in contrast to GABAergic inputs, which derive exclu-
sively from peri-PVN regions (Bali et al., 2005). In support, in situ
hybridization studies have revealed within the PVN the expression
of multiple ionotropic glutamate receptor subunits, particularly of
the NMDA receptor family (Herman et al., 2000; Ziegler et al.,
2005). In agreement, spontaneous action current ﬁring of mpd
neurones is abolished following the bath application of ionotropic
glutamate receptor antagonists e.g. kynurenic acid, or AP-5 and
DNQX (Zaki and Barrett-Jolley, 2002; Gunn et al., 2013) while
intra-PVN microinjections of kynurenic acid signiﬁcantly reduced
glucocorticoid release following exposure to acute restraint stress
(Ziegler and Herman, 2000). Collectively these ﬁndings support a
primary role for glutamate in driving the excitability of these
neurones.
Within the medial parvocellular region of the PVN, quantitative
ultrastructural analysis has revealed that CRF-releasing neurones
are the principle recipient of GABAergic inputs (Miklos and
Kovacs, 2002) and dual in situ hybridization and immuohistochem-
ical studies have demonstrated the expression of multiple GABAAR
subunits (e.g.a1,a2,a3,a5, b1-3 andc1,c2) in themajority of these
neurones (Cullinan, 2000; Hortnagl et al., 2013 – Fig. 1). In support,
the GABAAR antagonist, bicuculline, increases the frequency of
action current ﬁring of rodent mpd CRF-releasing neurones
(Hewitt et al., 2009;Gunnet al., 2013) and in agreement, plasmacor-
ticosterone levels increase, or decrease following the in vivomicro-
injectionof bicuculline (Cullinan et al., 2008;Hewitt et al., 2009) and
muscimol (Cullinan et al., 2008) respectively into the PVN.
The observations summarised above indicate that the balance
between glutamatergic and inhibitory GABAergic transmission
plays a fundamental role in regulating the output of the HPA axis.
As a corollary to this suggestion, modulation of GABAAR function
by endogenous neurosteroids may be important in ‘‘ﬁne tuning’’
HPA axis function. The following section will review evidence in
support of such a proposal and the relevance of these effects to
the anxiolytic actions of neurosteroids.
3.2. Stress and neurosteroids
The anxiolytic actions of the endogenous neurosteroid 5a3a-
THDOC were demonstrated almost 30 years ago (Crawley et al.,
Fig. 2. The stress neurocircuitry. A schematic representation of a sagittal section of a rodent brain, illustrating the neurocircuitry involved in the stress-induced regulation of
HPA axis activity, with a particular emphasis on the nature of direct excitatory (blue) and inhibitory (red) projections to the PVN and the complex polysynaptic inputs
mediating limbic and forebrain inﬂuences upon the stress response. The PVN receives direct noradrenergic, adrenergic and peptidergic innervation from the nucleus of
solitary tract (NTS), as well as direct PVN-projecting noradrenergic and serotonergic afferents originating in the locus coreleus (LC) and dorsal raphe nucleus (DR). Projection
from the bed nucleus of the stria terminalis (BST) are the main, non-hypothalamic forebrain inputs to the PVN, exerting both excitatory and inhibitory inﬂuences upon HPA
axis activity. Thus, glutamatergic and CRFergic projections to the PVN originating in the anterior BST (aBST) stimulate HPA axis activity, whilst inhibitory GABAergic inputs
originate in the posterior BST (pBST). Importantly the BST acts as primary relay site for limbic and forebrain inputs that have a substantial inﬂuence upon HPA axis activity (A,
B and C). Direct inhibitory inputs to the PVN originate in a number of hypothalamic nuclei (D), including the medial preoptic area (mPOA), ventrolateral dorsal hypothalamus
(vlDMH) and the peri-PVN (pPVN), while PVN-projecting afferents from the dorsomedial dorsal hypothalamus (dmDMH) provide intra-hypothalamic excitation to the HPA
axis. Limbic and forebrain regions impart a signiﬁcant inﬂuence upon the activity of the HPA axis, via indirect polysynaptic inputs to the PVN. The medial prefrontal cortex
(mPFC) inﬂuences HPA axis activity in a subregion-speciﬁc manner (A). Thus, the prelimbic (PL) mPFC inhibits response to psychogenic stressors primarily via glutamatergic
projections to inhibitory GABAergic relay nuclei (e.g. aBST, pPVN). In contrast, the infralimbic (IL) mPFC has been postulated to activate HPA axis activity possibly via
projections to the NTS and/or CeA. Hippocampal stress output is mediated by glutamtergic projections from the ventral subiculum (vSUB) to primarily GABAergic relay nuclei
(e.g. mPOA, pPVN, pBST and DMH), thereby inhibiting HPA axis activity (B). The amygdala exerts a primarily excitatory inﬂuence upon HPA axis activity, although this appears
to occur in a subregion and stressor speciﬁc manner. Inhibitory, GABAergic projections from the central (CeA) and medial (MeA) amygdala disinhibit GABAergic relay nuclei
(e.g. mPOA, aBST and DMH) to regulate responses to physical and psychogenic stressors respectively. Glutamatergic projections originating in the basolateral (BLA) amygdala
innervate the CeA, MeA and BST, primarily increasing HPA axis activity in general in response to psychogenic stressors (C). The lateral septum (LS) also modulates HPA axis
activity (pathways not shown) via polysynaptic inputs to the PVN. Furthermore, the nucleus accumbens (nAcc), which is primary component of the reward circuitry, may also
be important in the regulation of HPA axis activity, providing a structural connection between the stress and reward circuitry. Although the inﬂuence the nAcc imparts upon
HPA axis activity remains to be elucidated, projections from the nAcc core and shell to PVN-projecting brain regions such as the BST, lateral POA and lateral hypothalamus
(LH) provide an anatomical basis for potential physiological effects upon the HPA axis (not shown). Further evidence for an interaction between the reward and stress systems
is suggested by the observation that the receptors responsible for mediating the effects of glucocorticoids and CRF are expressed within the nAcc.
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dy in the early 1990s revealed that the brain levels of 5a3a-THDOC
and 5a3a-THPROG were rapidly elevated in the rodent cortex and
hypothalamus following exposure to acute swim stress that a
putative role for neurosteroids as regulators of the stress response
was postulated (Purdy et al., 1991). Of speciﬁc signiﬁcance, adre-
nalectomy prevented the stress-induced increase in 5a3a-THDOC,
but not 5a3a-THPROG, demonstrating the de novo brain synthesis
of the latter neurosteroid (Purdy et al., 1991). Such observations
suggested that neurosteroids synthesised de novo within the CNS
and those derived from peripheral sources may be important mod-
ulators of the behavioural and/or neuroendocrine response to
stress. Pertinent to such a hypothesis, the steroid synthesising
enzymes, 5a-reductase and 3a-HSD are expressed within the
hypothalamus (Li et al., 1997; Eechaute et al., 1999; Gao et al.,
2002), while 5a3a-THPROG immunoreactivity can be detected
within the extended amygdala and hypothalamus (Saalmann
et al., 2007). Furthermore, several investigations have demon-
strated similar increases in neurosteroid levels in response to a
range of different stressors (Barbaccia et al., 1994, 1996), while
the administration of 5a3a-THPROG and 5a3a-THDOC produce
anxiolytic effects in various test of anxiety in rodents (Bitran
et al., 1991; Wieland et al., 1991; Akwa et al., 1999). In further sup-
port, administration in rats of progesterone or agonists of TSPO
induced increased levels of 5a3a-THPROG within the brain, which
associated with anxiolytic-like effects that are attenuated by inhib-
itors of 5a-reductase or GABAAR antagonists (Bitran et al., 1995,
2000; Brot et al., 1997; Rupprecht et al., 2010).
The release of CRF from hypothalamic neuroendocrine parvo-
cellular neurones triggers the activation of the HPA axis (Vale
et al., 1981) and i.c.v. injection of this neuropeptide induces behav-
iours similar to those associated with stress and anxiety (Owens
and Nemeroff, 1991). Interestingly, the anxiogenic effects of CRF
in rats exposed to the elevated plus maze (EPM) can be prevented
in a dose-dependent manner by pre-treatment with 5a3a-THPROG
(Patchev et al., 1994). Furthermore, the pre-treatment of rats with
5a3a-THPROG, 5a3a-THDOC or PROG signiﬁcantly attenuates the
stress-induced increase in plasma ACTH and corticosterone
(Owens et al., 1992; Patchev et al., 1996). Consistent with such
in vivo actions, 5a3a-THPROG also suppresses the methoxamine
[an a1-adrenoreceptor (a1-AR) agonist]-induced release of CRF
in hypothalamic explant preparations, while having no effect upon
basal release of this neuropeptide (Patchev et al., 1994). Such an
effect is compatible with an action upon GABAAR as enhancement
of the GABAergic tone similarly inhibits CRF release from parvocel-
lular neurones (Owens et al., 1992). Congruent with such a pro-
posal, in electrophysiological recordings made from neonatal
(P18-26) mouse hypothalamus, we ﬁnd that low concentrations
(10–100 nM) of 5a3a-THPROG enhance GABAAR-mediated synap-
tic transmission of CRF-releasing mpd neurones of the PVN and
inhibit their output (Belelli et al., 2009; Gunn et al., 2013). Further-
more, low concentrations of the DOC metabolite, 5a3a-THDOC,
similarly reduces the output from neuroendocrine (Sarkar et al.,
2011) and spinally projecting parvocellular neurones (Womack
et al., 2006). The relevance of these studies in rodents to the regu-
lation of the stress response in humans is emphasised by the dem-
onstration that 5a-THDOC plasma levels exhibit a robust increase
in response to a cholecystokinin-tetrapeptide (CCK-4)-induced
panic attack in healthy volunteers. This increase is concomitant
to stimulation of ACTH and cortisol release, both hallmarks of
HPA axis activation, thus suggesting a speciﬁc possible role for
5a-THDOC in the termination of the stress/anxiety response fol-
lowing the CCK-4 challenge (Eser et al., 2005).
Collectively, the evidence gathered from molecular, immuno-
histochemical, electrophysiological and behavioural studies
strongly supports the notion that endogenous 3a-reduced neuros-teroids can reduce HPA axis activity by enhancing GABAAR function
and such an action is consistent with their anxiolytic-like proﬁle.
Amongst the speciﬁc molecular targets mediating the actions of
neurosteroids, the expression of a2-GABAAR in the PVN (see Sec-
tion 3.1 and Fig. 1) may be of particular signiﬁcance for their anx-
iolytic and stress-protective actions (Fig. 1). In agreement with this
suggestion, in a recent report, ‘‘knock-in’’ mice, expressing a neu-
rosteroid-insensitive a2 subunit (a2Q241M), exhibit an anxiogenic
phenotype and an impairment of the anxiolytic response to
injected neurosteroid, indicating a functional relevance (Durkin
et al., 2011). Moreover, a2-containing GABAARs have been shown
to mediate the anxiolytic action of classical BDZ’s, such as diaze-
pam (Low et al., 2000) and are highly expressed not only in PVN,
where the mRNA for the a2-subunit is highly co-localised with
CRF mRNA signal (Cullinan, 2000), but also in other stress-sensitive
brain regions including the amygdala, hippocampus and nucleus
accumbens (Fritschy and Mohler, 1995; Hortnagl et al., 2013).
Moreover, coupled with the inhibition of CRF, ACTH and corticoste-
rone release by 5a3a-THPROG described above (Owens et al.,
1992; Patchev et al., 1994, 1996), this ﬁnding is consistent with
the suggestion that potentiation of a2-GABAAR isoforms may spe-
ciﬁcally contribute to the anxiolytic proﬁle of neurosteroids.
Recently, the reported shift in the polarity of GABA actions
(from hyperpolarising to depolarising) in neuroendocrine parvo-
cellular neurones upon exposure to acute restraint stress (Hewitt
et al., 2009) has led to the proposal that stress-induced modulation
of GABAergic transmission by 5a3a-THDOC may actually facilitate
rather than restrain activation of the HPA axis (Sarkar et al., 2011).
Although such a scenario may be plausible, it does not appear com-
patible with their well-documented anxiolytic-like properties and
the inhibitory actions of 5a3a-THPROG upon CRF, ACTH and corti-
costerone release as discussed above. Furthermore, the temporal
proﬁles of the observed changes in GABAergic transmission and
behavioural parameters on one side, and the stress-induced
increase in neurosteroid levels on the other appear incongruent
with a facilitatory effect of neurosteroid upon HPA axis activation.
Thus, a decrease in GABAergic transmission and comparable
changes in behavioural parameters related to GABAergic transmis-
sion occur rapidly (within 5 min) and with a similar time course
following stressor exposure (Sanna et al., 1992; Barbaccia et al.,
1996; Biggio et al., 2007). However, the levels of neurosteroids
peak both in the whole brain and in the hypothalamus with a delay
of 30–60 min after a stressful challenge (Purdy et al., 1991;
Barbaccia et al., 2001), a time course mimicked by inducing stress
by the direct injection of CRH, or ACTH (Torres et al., 2001). This
temporal proﬁle parallels the manifestation of their anxiolytic-like
properties, a synchrony that appears incompatible with a facilita-
tion of HPA axis activity.
In further albeit indirect support, the effect of stress on neuros-
teroid levels is mimicked by treatment with an anxiogenic GABAAR
acting ligand but antagonized by anxiolytic benzodiazepines
(Barbaccia et al., 1996; Biggio et al., 2007). Thus, neurosteroids
appear to act in an adaptive fashion to curtail the extent and dura-
tion of the stress-induced inhibition of GABAergic transmission.
Nevertheless, as noted above, other stress-sensitive regions impli-
cated in the regulation of emotional states, e.g. hippocampus and
amygdala, will contribute their anxiolytic properties (Bitran
et al., 1999).4. Programing of the stress neurocircuitry: a role for
endogenous neurosteroids?
Throughout the lifespan, exposure to physiological and environ-
mental challenges can have profound and enduring effects upon
stress susceptibility and resilience (Lupien et al., 2009). However,
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critical for brain development, and stressor exposure at this stage
can severely alter physiological, behavioural and cognitive func-
tions during adolescence and adulthood (McEwen, 2003; Bale
et al., 2010; Franklin et al., 2012; Brunton et al., 2014). The follow-
ing section will introduce how early postnatal experiences can
modulate neurodevelopment with an emphasis on (1) the poten-
tial role for endogenous neurosteroids in the maturation of the
HPA axis and overall stress neurocircuitry and (2) the impact of
early-life adversity upon the stress-protective actions of endoge-
nous neurosteroids. For a detailed discussion on the role of prena-
tal experience and speciﬁcally stress on programming of the HPA
axis, see recent reviews Bale et al., 2010; Brunton and Russell,
2011; Brunton et al., 2014.
4.1. Early-life experience and HPA maturation
In rodents, the early postnatal period, is characterised by a
marked hyporesponsivity of the HPA axis, occurring during days
4–14 of life (Sapolsky and Meaney, 1986). This ‘hyporesponsive’
period coincides with stages of axonal growth, synaptogenesis
and myelination within key brain neurocircuits, and as such it
has been postulated that the dampening of HPA axis reactivity,
via a pituitary-mediated mechanisms involving GR inhibition of
ACTH release (Schmidt, 2010), is an important mechanism for pro-
tecting the developing brain from excessive levels of glucocorti-
coids (Sapolsky and Meaney, 1986). Interestingly, alterations in
the activation of limbic and forebrain GABAergic circuits have been
implicated as potential candidates underlying reduced HPA func-
tion during the stress hyporesponsive period (Dent et al., 2007).
The mother–pup interaction in rodents is crucial for the matura-
tion of the HPA axis, and alterations in the level of maternal behav-
iours, such as licking-grooming (LG) and arched back nursing
(ABN) can signiﬁcantly inﬂuence the behavioural and neuroendo-
crine response to stress in adulthood (Liu et al., 1997; Francis
and Meaney, 1999). Speciﬁcally, the adult offspring of high-com-
pared to low-LG-ABN mothers exhibited decreased levels of hypo-
thalamic CRF mRNA and increased hippocampal GR mRNA
expression, which was accompanied by an increased sensitivity
to glucocorticoid feedback and more modest HPA responses to
acute stress (Liu et al., 1997). Interestingly, cross-fostering studies
have revealed that these variations in maternal care may serve as a
mechanism for the non-genomic transmission of individual differ-
ences in stress reactivity across generations e.g. via epigenetic
mechanisms (Francis et al., 1999). The subsequent ﬁnding that
alterations in hippocampal GR expression associated with differing
levels of maternal care were caused by differences in DNA methyl-
ation of the GR gene promoter region and alterations in histone
acetylation (Weaver et al., 2004) provided the ﬁrst demonstration
that maternal care can indeed modify the epigenomic state of
stress-related genes. Moreover, these observations identiﬁed epi-
genetic modiﬁcations as candidate mechanisms to mediate gene-
environment interactions that impact upon the maturation of the
stress axis (Vialou et al., 2013).
Experimentally-induced manipulations to either enhance or
impair maternal care have proved useful approaches to investigate
the mechanisms underlying the neurobiological plasticity associ-
ated with early-life experience and maturation of the HPA axis
(reviewed in Meaney, 2001; Franklin et al., 2012). For example,
in rodents, postnatal handling comprising of short periods (i.e. 3–
15 min) of daily separation of the pups from their mother during
the ﬁrst week(s) of life, promotes increased active maternal behav-
iours (i.e. LG, ABN) following the return of the pups to the home
cage (Pryce et al., 2001; Fenoglio et al., 2006b). Similar to pups
exposed to high levels of maternal care, early handling has been
shown to result in decreased stress reactivity in adulthood,reduced hypothalamic CRF expression and increased hippocampal
GR (Liu et al., 1997; Francis and Meaney, 1999; Sanchez et al.,
2001). In contrast, adult offspring exposed to longer recurrent daily
periods of maternal separation (e.g. 2–3 h) during the early postna-
tal period (e.g. P2-P14) displayed a signiﬁcantly increased HPA
response to acute stress, which was accompanied by a reduction
in the expression of hippocampal GR mRNA and increased CRF
mRNA in the hypothalamic PVN (Francis and Meaney, 1999;
Meaney, 2001; Cirulli et al., 2003; Schmidt et al., 2004 although
see Pryce et al., 2001; Lehmann et al., 2002). Interestingly, in a
model of augmented maternal care, reprogramming of the stress
response is mediated early-on (by P9) by a decreased expression
of CRF in neurones of the PVN and only at later developmental
stages by a reduced hormonal response to stressor exposure (by
P23) and an epigenetically-induced enhancement of hippocampal
GR expression (to increase the GR negative feedback), which takes
place between P23-P45 (Avishai-Eliner et al., 2001; Korosi and
Baram, 2009). Such observations suggest that plasticity of hypo-
thalamic CRF-releasing neurones, resulting in the suppression of
crh gene expression, is an early and potentially important process
in the mechanism(s) responsible for mediating the effects of
increased maternal care upon the stress response. Although not
yet elucidated, it seems plausible that a similar temporal proﬁle
may be associated with the alterations in hypothalamic CRF, endo-
crine stress response and hippocampal GR expression that accom-
pany negative early life experience (e.g. maternal separation, or
fragmentation – see below).
4.2. Neurosteroids and HPA development
A potential physiological role for neurosteroids in the program-
ming of the stress response was ﬁrst proposed following the obser-
vation that administration of 5a3a-THPROG reduced the number
of ultrasonic vocalisations (USVs), a measure of an anxious-like
phenotype, in neonatal rat pups (P7) previously exposed to mater-
nal separation (Zimmerberg et al., 1994, 1999). In support, in adult
rats, the behavioural and neuroendocrine effects of repeated
maternal separation early in life (P2-P10) were attenuated when
5a3a-THDOC was concomitantly administered during the separa-
tion period (Patchev et al., 1997). Consistent with a putative phys-
iological role of neurosteroids early in life, the levels of 3a-HSD
mRNA are elevated in the dentate gyrus of male and female rats
at P7 (Mitev et al., 2003). Interestingly, the behavioural and neuro-
endocrine dysregulation associated with maternal separation in
rats shows a gender speciﬁc proﬁle as adult male, but not female
rats displayed an anxious phenotype on the EPM following mater-
nal separation (P5-P6; Mitev et al., 2003), although such effects
may be additionally dependent upon the maternal separation pro-
tocol used (Zimmerberg and Kajunski, 2004). These sex-speciﬁc
effects are likely to be a consequence of increased peripherally
derived steroids (e.g. estrogen, progesterone) in females, as overec-
tomised (OVX) female rats exposed to maternal separation exhib-
ited an anxious-like phenotype on the EPM comparable to that
observed in males. Interestingly, however, the concomitant admin-
istration of 5a3a-THPROG during maternal separation attenuated
the behavioural and neuroendocrine consequences associated with
postnatal stress in both genders (Mitev et al., 2003). Similar gen-
der-speciﬁc regulation of neurosteroidogenesis has been described
for the mPFC where restrain stress increased the mRNA and protein
levels of 5a-reductase more signiﬁcantly in male compared to
female rats (Sanchez et al., 2009).
More recent studies have revealed that elevating the levels of
neonatal (P5) 5a3a-THPROG altered exploratory and anxiety-like
behaviours in adulthood (Modol et al., 2013), while reducing neu-
rosteroid levels with the 5a-reductase inhibitor, ﬁnasteride pro-
duced an anxiogenic-like phenotype (Martin-Garcia et al., 2008).
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teroids may regulate maturation of the HPA axis remain to be iden-
tiﬁed but the observation that during the ﬁrst postnatal week
activation of GABAAR mediates a depolarising response and thus
may lead to secondary Ca2+ inﬂux to trigger second-messenger-
mediated changes in gene expression or protein function offers
scope for future investigations (Fig. 4).5. The effect of early-life experience upon neuroplasticity of the
stress neurocircutry: a focus on GABAAR mediated inhibition
and relevance to neurosteroid actions5.1. Neuroplasticity of the PVN
The observation that a reduction in hypothalamic CRF expres-
sion precedes the reduced hormonal stress response and the epige-
netically augmented expression of hippocampal GRs
accompanying early handling (Avishai-Eliner et al., 2001; Korosi
and Baram, 2009) suggests that plasticity of the hypothalamic
CRF-releasing neurone is an early and important component of
experience-induced programming of the stress response. There-
fore, understanding the molecular and functional changes that
occur in these neurones in response to variable maternal sensory
inputs has been the focus of recent research. As described above
(Section3.1) CRF-releasing neurones of the PVN receive excitatory
glutamatergic, and inhibitory GABAergic inputs that signal via glu-
tamate and GABAA receptors respectively. Thus, recent studies
have investigated whether augmented maternal care induces alter-
ations in excitatory and inhibitory inputs to these neurones (Korosi
et al., 2010). A combined approach of quantitative confocal micros-
copy, electron microscopy and electrophysiology, has revealed
augmented maternal care to associate with a signiﬁcant and selec-
tive reduction in the number of glutamatergic but not GABAergic
synapses onto CRF neurones (Korosi et al., 2010). This neuroplastic-
ity in excitatory transmission is accompanied by an increased
expression of the transcriptional repressor neuron-restrictive
silencing factor (NRSF), which negatively regulates crh gene tran-
scription. Interestingly, although the reduced excitatory drive onto
CRF-releasing neurones dissipated by adulthood, the elevated NRSF
levels and suppression of CRF expression were preserved (Korosi
et al., 2010), suggesting that reduced glutamatergic transmission
in the developing PVN though crucial to initiate the reprogram-
ming of CRF expression, is not necessary for its maintenance. In
support of such a notion, recent studies using hypothalamic neuro-
nal cultures have revealed that pharmacological blockade of iono-
tropic glutamate receptors is sufﬁcient to down-regulate the
expression of CRF mRNA (Karsten and Baram, 2013).
More recently, we have explored whether an analogous albeit
opposite form of neuroplasticity may take place in CRF-releasing
neurones following a reverse manipulation i.e. exposure to adverse
early-life experiences. Converging evidence from various laborato-
ries has indicated a lack of consistent effects upon HPA program-
ming by maternal separation protocols in mice (Millstein and
Holmes, 2007; Own and Patel, 2013). Thus, we adopted a model
of fragmented maternal care that produces enduring neuroendo-
crine and behavioural abnormalities (Rice et al., 2008). This exper-
imental paradigm is based on a reduction of the nesting material
(2/3) and the introduction of a ﬁne gauge steel grid to house the
dam and pups in order to prevent stable nest formation. Such an
environment induces alterations in the maternal behaviour of the
dam (i.e. shortened bout of nurturing behaviour and frequent shifts
between behaviours) and recapitulates an important element of
neglect in humans where the mother is present, yet the quality
of care is impaired (Korosi and Baram, 2009; Baram et al., 2012).
We have utilised a combined electrophysiological and immunohis-tochemical approach to investigate possible alterations in the
inhibitory–excitatory balance impinging upon CRF-releasing neu-
rones as a consequence of chronic ELS exposure in neonatal mice
(P18-P26). Consistent with the working hypothesis, ELS induced
a signiﬁcant increase in the number and function of glutamatergic
synapses apposing CRF-releasing neurones, whereas only modest
plasticity was associated with the GABAergic inputs to these
neurones (Gunn et al., 2013). Most prominently, a concomitant
dramatic increase in the tonic glutamatergic conductance of CRF-
releasing neurones was apparent for ELS-exposed mice and this
up-regulation appeared to originate from impaired astrocytic func-
tion of the glutamate transporter (Gunn et al., 2013 – Fig. 3). Inter-
estingly, the ELS-induced increase of the excitatory drive onto CRF
neurones blunted inhibition of action potential ﬁring in these neu-
rones by physiologically relevant concentrations of 5a3a-THPROG
(Fig. 3). This observation suggests that in response to a stressful
challenge, the inhibitory actions of the stress-induced levels of
neurosteroids (Purdy et al., 1991) may be compromised during
adolescence and possibly in adulthood as a consequence of the
plasticity induced by the negative early-life experience (Gunn
et al., 2013). Although, only modest changes in GABAAR-mediated
inhibition could be detected, a more detailed investigation is
required to determine whether ELS exposure induces alterations
in the expression of speciﬁc GABAAR isoforms or indeed the subcel-
lular localisation of GABAergic inputs to mpd neurones (e.g. see
Miklos and Kovacs, 2012).
Intriguingly, we have found that mice lacking the d subunit of
the GABAAR (d0/0 mice) share with ELS mice similar PVN glutama-
tergic plasticity,namely an increased synaptic and extrasynaptic
glutamatergic drive and a blunted neurosteroid action upon the
neuronal discharge of CRF-releasing neurones (Gunn et al., 2013).
These ﬁndings may appear paradoxical, as extrasynaptic d-contain-
ing GABAARs, a putatively highly sensitive neurosteroid target
(Belelli et al., 2002, 2009; Brown et al., 2002) are not expressed
within the PVN (Wisden et al., 1992; Fritschy and Mohler, 1995,
Hortnagl et al., 2013; Gunn et al., 2013 although see Sarkar et al.,
2011). However, a plausible explanation is offered by the observa-
tion that d0/0 pups exhibit phenotypic features of abnormal mater-
nal care (Maguire and Mody, 2008; Gunn et al., 2013), and in
agreement, in common with ELS mice, display a signiﬁcant and
long lasting up-regulation of CRF expression within the PVN Fur-
thermore, exposure to early-life adversity dramatically exacer-
bates the d0/0 phenotype with greatly increased perinatal and
adult mortality (Gunn et al., 2013). A reduced maternal care for
d0/0 pups may not be altogether unexpected given that an
increased dopamine release from the ventral tegmental area
(VTA) to the nucleus accumbens shell in the dam is associated with
the onset, duration and magnitude of licking-grooming bouts, an
important component of maternal care in rodents (Champagne
et al., 2004; Russo and Nestler, 2013), and presynaptic d-GABAARs
may regulate the dopaminergic output of VTA neurones (Xiao et al.,
2007; Vashchinkina et al., 2012). Further, intriguingly, a mouse
model of chronic stress exhibits a long-lasting signiﬁcant decrease
in d-GABAAR expression in the VTA (Warren et al., 2013). Neverthe-
less, additional studies, such as cross-fostering (Priebe et al., 2005),
are required to establish the relative contribution genetic and envi-
ronmental factors make to the described d0/0 phenotype (Maguire
and Mody, 2008; Gunn et al., 2013). In this regard, the reported
association of SNPs in the GABRD gene with childhood-onset mood
disorders raises the prospect that speciﬁc GABAAR genetic abnor-
malities may underlie susceptibility to stressful experiences and
thus contribute to the development of psychopathology in humans
(Feng et al., 2010).
Given the pivotal role of NRSF in the regulation of CRF gene
expression in the mouse model of augmented maternal care
described by Korosi et al. (2010), the contribution of NRSF, or
Fig. 3. Adverse early-life experience induces signiﬁcant functional and morphological plasticity in the neonatal mouse PVN. A. Immunohistochemical analysis illustrating the
expression of CRF (pink) and the astrocytic cytoskeleton protein GFAP (green) in coronal sections of the neonatal hypothalamic PVN under control breeding conditions (left)
and following exposure to ELS (right). Note that following ELS the expression of CRF in medial parvocellular neurones (mpd) increases while GFAP immunoreactive arbours
become thinner. B. Immunuhistochemical analysis illustrating at high magniﬁcation the excitatory glutamatergic inputs measured by vGLUT2 expression (blue) apposing
neonatal CRF-releasing neurones of mice bred under normal condition (left) or exposed to ELS (right). Note the signiﬁcant increase in the number of excitatory glutamatergic
(blue) inputs apposing neonatal CRF-releasing neurones exposed to ELS. C. Diagrammatic representation of the changes occurring at the glutamatergic synapses of CRF-
releasing mpd neurones as a consequence of abnormal maternal care. Functional and molecular ﬁndings indicate an increase in phasic glutamatergic currents and an elevated
excitatory tonic conductance in ELS compared to control neurones. The latter effect in mice exposed to ELS is mediated, at least in part, by the reduced clearance of glutamate
from the synapse caused by a reduction in the expression of astrocytic glutamate transporters. In ELS-exposed mice, the increased glutamatergic drive associates with a loss
of the inhibitory actions of the naturally occurring progesterone metabolite 5a3a THPROG upon the neuronal discharge of CRF-releasing mpd neurones. In this regard,
compare cell-attached recordings before and after 5a3a THPROG shown to the right and left side of the diagrammatic synapses for Control and ELS neurones respectively.
Note that the changes described above for ELS mice are shared by a genetic mouse model of postnatal depression, the d ‘‘knock-out’’ mice, which also experience abnormal
maternal care (Gunn et al., 2013).
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spring of models of impaired maternal cares (e.g. of ELS and d0/0)
deserve a detailed investigation. Nevertheless, the evidence
described is consistent with the notion that alterations in excit-
atory glutamatergic transmission coupled with blunted neuroster-
oid actions early in postnatal development may be an important
molecular signal to initiate programming of the stress axis. Further,
from a clinical perspective, abnormal regulation of glutamatergic
transmission in animal models of chronic stress appear relevant
and consistent with recent therapeutic strategies targeting inhibi-tion of ionotropic glutamate receptors, e.g. NMDA receptors for the
treatment of stress-related psychiatric disturbances e.g. depression
(Niciu et al., 2014).
5.2. Neuroplasticity of extra-hypothalamic stress centres
As described in Section 3.1, the hypothalamic PVN sub-serves
the combined role of integrating multiple inputs from hypotha-
lamic and extra-hypothalamic stress-responsive regions and initi-
ating the stress response. However, multiple forebrain and limbic
38 B.G. Gunn et al. / Frontiers in Neuroendocrinology 35 (2015) 28–48structures, including the hippocampus, amygdala and mPFC appear
to operate in a parallel fashion to process and integrate psycho-
genic and systemic stimuli to coordinate HPA axis activity appro-
priately. The network activity of these limbic regions is
determined in a large part by the activity of inhibitory GABAergic
interneurons (Klausberger and Somogyi, 2008; Ehrlich et al.,
2009; Taniguchi, 2014), and as such, dysfunction in GABAergic
transmission within these brain regions may be predicted to
impart susceptibility to stressor exposure and to the development
of psychiatric disorders. Indeed, there is substantial preclinical and
clinical evidence indicating that alterations in GABAergic inhibition
may be a contributing factor in the pathogenesis of affective disor-
ders such as depression (see section below; Krystal et al., 2002;
Sanacora et al., 2004; Luscher et al., 2011; Maciag et al., 2010).
As noted above, we have found in mice that exposure to frag-
mented maternal care early in life results in limited apparent plas-
ticity in the GABAergic inputs to PVN mpd neurones (although see
below). However, there is substantial evidence that early-life expe-
riences causes alterations in GABAAR-mediated signalling in other
stress-sensitive brain regions. The following sections will discuss
the inﬂuence of early-life experience upon the maturation of GAB-
Aergic circuits within these limbic and forebrain regions, highlight-
ing the potential role for neurosteroids within this process and the
implications that plasticity in these brain structures may have
upon the actions of these endogenous modulators upon GABAergic
transmission.
The quality of early-life experience has been associated with
alterations in GABAAR subunit expression in a number of brain
regions within the stress neurocircuitry. Moreover, such plasticity
appears concomitant to perturbations in behavioural and neuroen-
docrine responses to stressor exposure in adulthood (Caldji et al.,
1998, 2000, 2003; Hsu et al., 2003). Alterations in GABAAR expres-
sion in regions of the amygdala, NTS and locus coeruleus (LC) were
inferred from autoradiography binding studies using [3H] ﬂunitraz-
epam, where animals exposed to postnatal handling (P1–P14)
displayed an increase in central BDZ binding compared to non-
handled and maternally separated rats (Caldji et al., 2000). This
increase in central BDZ binding in handled animals was accompa-
nied by an increase in c2 mRNA in these brain regions and reduced
fearfulness in response to novelty (Caldji et al., 2000). Comparable
perturbations, namely a signiﬁcant reduction in the expression of
the a1 subunit but up-regulation of a2 subunit levels, have been
described for DGGCs of rat pups exposed to two periods of han-
dling with maternal separation (HMS) on P9 (30 min) and P10
(360 min; Hsu et al., 2003). In general, adult offspring that received
a high level of maternal care (i.e. high LG-ABN) displayed signiﬁ-
cantly greater mRNA encoding a1 and b3 subunits in limbic and
forebrain regions when compared to those that received low levels
of maternal care (Caldji et al., 2003). Intriguingly, alterations in
GABAAR subunit expression associated with variations in maternal
care are most pronounced in regions of the amygdaloid complex,
an important brain region for the processing of ‘‘psychogenic’’
stressors (Ulrich-lai and Herman, 2009) and a key area implicated
in the development of fear learning (Roozendaal et al., 2009). Spe-
ciﬁcally, the central (CeA), basolateral (BLA) and lateral (LA) amyg-
daloid nuclei of adult offspring that experienced high-levels of
maternal care, displayed signiﬁcantly greater mRNA expression
levels of both c1 and c2 subunits, the latter being important in
mediating the majority of actions by benzodiazepines. Conversely,
the mRNA levels of a3 and the BZ-insensitive a4 subunit increased
in the CeA and BLA of mice exposed to low quality maternal care
(Caldji et al., 2003). Such changes will impact upon the functional
and pharmacological properties of GABAA receptors, including,
potentially their sensitivity to neurosteroids. However, as noted
above (Sections 1 and 2) in addition to the receptor subunit com-
position, the effects of neurosteroids are potentially, inﬂuencedby other mechanisms such as local steroid metabolism and phos-
phorylation state of the receptor or associated proteins (Herd
et al., 2007). Thus, elucidating possible alterations in these regula-
tory processes e.g. altered expression of steroidoigenic enzymes,
may warrant future detailed investigations. A precedent in this
respect is offered by the demonstrated alteration in the activity
of steroidogenic enzymes e.g. 5a-reductase in forebrain regions
in a socially isolated mouse model of chronic stress (Dong et al.,
2001a; Pibiri et al., 2008).
The amygdala has been identiﬁed as a key structure in mediat-
ing the anxiolytic (Akwa et al., 1999; Engin and Treit, 2007) and the
antidepressant (Shirayama et al., 2011) effects of 5a3a-THPROG.
Therefore, for this brain region understanding the impact of such
alterations in GABAAR gene expression on synaptic and extrasy-
naptic inhibitory signalling may be particularly pertinent.
The ELS–induced alterations in GABAAR expression in the extra-
hypothalamic regions described above are likely to occur in con-
junction with alterations in excitatory glutamatergic transmission.
Similarly to the GABAergic system, relatively little is known
regarding the speciﬁc functional alterations in glutamatergic trans-
mission at the synaptic level (i.e. properties of EPSCs) within limbic
and forebrain structures following early life stress. However, per-
turbations in glutamatergic transmission have been inferred from
morphological and functional studies, primarily in the hippocam-
pus (Martisova et al., 2012). For example, in rats, exposure to frag-
mented early-life stress (as described for mice in Section 5.1)
results in signiﬁcant cognitive deﬁcits in adulthood (Brunson
et al., 2005; Ivy et al., 2010), which are associated with impaired
hippocampal LTP, dendritic atrophy and a reduction in spine num-
bers (Brunson et al., 2005; Ivy et al., 2010; Wang et al., 2011
reviewed in Regev and Baram, 2014). Furthermore, in rats, off-
spring exposed to low levels of maternal care exhibited enhanced
basal NMDAR function (measured by an increase in NMDA/AMPA
evoked EPSCs ratio) in the DG, which was associated with
increased NR1, NR2A and NR2B expression (Bagot et al., 2012
reviewed in Tse et al., 2012; Timmermans et al., 2013). Collectively
these observations indicate alterations in glutamatergic transmis-
sion in stress-related brain regions are likely to accompany
stress-induced plasticity in the GABAergic system during develop-
ment. Elucidating the speciﬁc functional changes in excitatory/
inhibitory balance both at the synaptic and extrasynaptic levels
and establishing how plasticity in the GABAergic and glutamater-
gic systems may interact to inﬂuence network activity, and hence
output from these extra-hypothalamic brain areas, should offer an
important focused scope for future studies.6. Stress-associated interneuron plasticity and neurosteroids
6.1. Dysfunction of the GABAergic system
Exposure to early-life stress has consistently been shown to
induce signiﬁcant plasticity in the functional and morphological
properties of principal cells in limbic and forebrain regions
(Fenoglio et al., 2006a; Lupien et al., 2009; McEwen and
Morrison, 2013; Regev and Baram, 2014), However, the changes
in the expression of GABAAR subunits in limbic and forebrain
regions induced by early-life experience may also be accompanied
by alterations in the number and/or localisation of GABAergic
interneurons including those surrounding the PVN region (Bali
et al., 2005). Such adaptations may have a signiﬁcant impact upon
the development of an organism’s ability to process and cope with
stressor exposure. Indeed, GABAergic interneurons represent a
highly diverse class of inhibitory neurones that interact with gluta-
matergic principal cells in a domain-speciﬁc manner, supporting
the temporal dynamics of synaptic transmission and network
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brain states (Markram et al., 2004; Klausberger and Somogyi,
2008; Lewis et al., 2012). Alterations to interneurone function
albeit with some differences dependent on the species investigated
and the protocol employed, have been inferred from immunohisto-
chemical studies measuring the levels of calcium binding proteins
[CBPs e.g. parvalbumin (PV), calretinin, calbindin] expressed pri-
marily in GABAergic interneurons. Thus, a number of rodent brain
regions including the prelimbic prefrontal cortex (plPFC)
(Brenhouse and Andersen, 2011), anterior cingulate cortex (ACd),
precentral medial cortex (PrCm; Helmeke et al., 2008) and the den-
tate gyrus (Seidel et al., 2008) exhibit reduced levels of CBPs fol-
lowing various manipulations of maternal care. Although these
studies do not provide direct functional evidence supporting ELS-
induced alterations in GABAergic transmission, they do suggest
potential plasticity of inhibitory interneurons following ELS, as
the reduced PV expression is indicative either of a decrease in
interneuron numbers, and/or alterations in interneuron activity.
A precedent in this regard is offered by the documented association
between abnormal cortical levels of PV and GABAergic dysfunction
both in animal models of schizophrenia and schizophrenic patients
(Lewis et al., 2012). Furthermore, clinical studies also highlight a
loss of GABAergic interneurons in patients suffering from stress-
related psychopatholgy e.g., depression (Maciag et al., 2010) and
a loss of GABAergic signals is apparent in imaging studies
(Sanacora et al., 1999).
Different types of inhibitory interneurons synapse onto distinct
subcellular regions of principle cells (e.g. axon initial segment,
dendrites, cell soma), thereby imparting distinct spatiotemporal
GABAergic conductances onto the pyramidal cell, the pattern of
which changes during particular physiological and pathophysio-
logical states (Lewis et al., 2012; Takesian and Hensch, 2013). Both
in the hippocampus and cortex, current evidence supports a selec-
tive targeting of interneuron subtype to principal neurones cellular
domains associated with the expression of a distinct GABAAR
subunit complement (Mohler, 2012; Fritschy and Panzanelli, 2014).
Thus, experience-induced alterations in dendritic/axonal morphol-
ogy, associated changes to the subcellular localisation of
GABAergic interneuron synapses onto principle cells, or functional
plasticity in the GABAARs expressed at these distinct synapses, may
signiﬁcantly inﬂuence the neuronal and behavioural response to
stress in adulthood. In support of such a notion, the propagation
of locally evoked activity in the DG relative to that evoked the in
CA1 was reduced in a rodent model (chronic mild stress [CMS])
of depression. Importantly such a reduction in activity propagation
in the DG relative to the CA1 was associated with the behavioural
phenotype of CMS-exposed animals in the forced swim (FST) and
open ﬁeld tests (OFT). These ﬁndings are consistent with the pro-
posal that alterations in network dynamics may underlie behav-
ioural changes accompanying chronic stress (Airan et al., 2007).
6.2. Stress-associated plasticity: a role for neurosteroids?
The early postnatal period, which is characterised by the stress-
hyporesponsive period (SHRP, P2–P14 – Fig. 4), represents a time
of considerable plasticity within the CNS with ongoing neuronal
migration, synaptogenesis and apoptosis. Interestingly, in rodents
the cortical levels of the endogenous neurosteroid, 5a3a-THPROG
vary considerably during postnatal development, falling precipi-
tously prior to parturition and remaining relatively lower for the
ﬁrst week of life (Grobin and Morrow, 2001 – Fig. 4) . However,
during the second postnatal week, a transient increase in the levels
of 5a3a-THPROG between P10–P14 is observed, which return to
low adult levels on P15 (Grobin and Morrow, 2001 – Fig. 4). This
dynamic regulation of neurosteroid levels during early develop-
mental stages raises the prospect of a likely physiological role forneurosteroids in cortical maturation. Consistent with such a
notion, perturbations in the levels of endogenous neurosteroids,
such as 5a3a-THPROG during early postnatal development have
a signiﬁcant impact upon the localisation of PV-expressing GAB-
Aergic interneurons of the PFC in adulthood (Grobin et al., 2003).
Speciﬁcally, the ratio of PV-expressing neurones in the deep (layers
V–VI) vs superﬁcial (layers I–III) layers of adult PFC is increased
two fold in rats following neonatal (P1 or P5) administration of
5a3a-THPROG (10 mg/kg – Grobin et al., 2003). An enhancement
of GABAAR function by the neurosteroid appears to be the likely
mechanism underlying the observed anatomical rearrangement
as similar changes in interneuron placement become apparent fol-
lowing postnatal exposure to the benzodiazepine, ﬂunitrazepam
(Grobin et al., 2004). Such an effect of 5a3a-THPROG upon inter-
neuron localisation is consistent with the observation that ambient
GABA promotes cortical entry of tangentially migrating neurons
derived from the medial ganglionic eminence (MGE). Similarly, a
BZ (diazepam)-mediated enhancement of GABAAR function
increased the migration of MGE neurones (Cuzon et al., 2006).
Interestingly, prenatal exposure to ethanol also promotes prema-
ture tangential migration of GABAergic interneurons (a proportion
of which originate in the MGE) by increasing the ambient levels of
GABA and enhancing the sensitivity of migrating interneurons to
this neurotransmitter (Cuzon et al., 2008). Given the documented
effects of both BZs and ethanol upon hippocampal neurosteroidge-
neis (Morrow et al., 2006, 2009; Tokuda et al., 2010, 2011; see Sec-
tion 2.2), it is tempting to speculate that at least some of these
effects may be indeed mediated by endogenous neurosteroids
(Morrow et al., 2006, 2009; Tokuda et al., 2010, 2011). Neverthe-
less it should be noted that dynamic alterations in GABAAR subunit
expression have also been implicated in the process of interneuron
migration (Cuzon Carlson and Yeh, 2011) and thus, may provide an
additional potential direct or indirect e.g. via neurosteroids mech-
anism for the enhanced GABA sensitivity following ethanol expo-
sure. Moreover, intriguingly, the secondary early postnatal
neurosteroid peak at P10 in cortex coincides with the switch in
the polarity of GABA actions from depolarising to hyperpolarising
(due to the increased expression of the potassium-chloride co-
transporter, KCC2 and subsequent reduction in intracellular Cl-
concentration – Fig. 4) suggesting a possible mechanistic link
between the two phenomena.
A much improved understanding of the impact of early life
adversity upon the integration and localisation of interneurons
into principle cell networks and the timing of the switch in the
polarity of the GABA response offers ample and immediate scope
for future investigations. As disruption of maternal care alters hip-
pocampal neurosteroid levels (Kehoe et al., 2000; Frye et al., 2006),
it is reasonable to predict that changes in neurosteroidogenesis
may occur in a number of brain regions and thus, may be a more
widespread important mechanism contributing to early-life
stress-induced neuronal plasticity than is currently appreciated.7. Neurosteroid action, GABAARs and stress: implications for
stress-related psychopathology
It is widely accepted that stress represents a signiﬁcant risk fac-
tor for the development of psychiatric disturbances e.g. depression
(Lupien et al., 2009; Heim et al., 2010; Sickmann et al., 2014).
Despite the prevalence of major depressive disorders as a leading
cause of disability worldwide, the neurobiological processes that
underlie the emotional, cognitive and neuroendocrine perturba-
tions associated with these multifactorial disorders remains
relatively poorly understood, hindering the development of novel
therapeutics. Speciﬁcally, the most commonly prescribed
antidepressants, the selective serotonin reuptake inhibitors (e.g.
Fig. 4. The brain levels of 5a3a-THPROG are developmentally regulated. Diagrammatic illustration of rat cortical levels (arbitrary units) of 5a3a-THPROG across various
developmental stages. During embryonic development the levels of 5a3a-THPROG decrease considerably at E20 before increasing prior to parturition. The relatively high
levels of 5a3a-THPROG at birth (P0), decline gradually over the ﬁrst postnatal week until P10, when they rise again to levels comparable to those observed at birth. This
transient increase lasts until P15, when the levels of 5a3a-THPROG decline back to basal values. Interestingly, the early postnatal period, which is associated with generally
elevated levels of 5a3a-THPROG coincides with the so-called stress hypo-responsive period (SHRP, P2-P14). Furthermore, the secondary transient peak (at P10) in cortical
neurosteroid levels coincides with signiﬁcant developmental changes associated with GABAAR-mediated inhibition within the CNS. As detailed, during this developmental
stage, at P9–P10 the actions of GABA switch from being depolarising to hyperpolarising as a consequence of the increased expression of the potassium-chloride co-
transporter, KCC2, thus causing a subsequent reduction in intracellular Cl-concentration. Shortly after this change, the further development of the rodent visual cortex begins
at P14 following eye opening. This early period of signiﬁcant neuronal and network maturation is additionally accompanied by signiﬁcant developmental changes in the
GABAAR subunit expression, typiﬁed by a switch from the embryonic a2/3 to adult a1 subunits, which takes places throughout the second and third postnatal weeks.
Although, in adulthood the basal levels of 5a3a-THPROG are typically lower than during early postnatal development, they are dynamically elevated in response to speciﬁc
physiological conditions, including acute stressor exposure and during pregnancy.
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(2–3 weeks) and are only moderately effective, with more than
one third of depressed patients remaining treatment-resistant
(Racagni and Popoli, 2008). Over recent years signiﬁcant efforts
to identify novel pathogenic and therapeutically relevant mecha-
nisms for major depressive disorders have gathered convincing
evidence from both preclinical and clinical studies implicating
both GABAergic and glutamatergic systems (Sanacora et al., 1999,
2012; Krystal et al., 2002; Luscher et al., 2011; Popoli et al.,
2012). Such ﬁndings are consistent with (i) a prominent role
played by the excitatory-inhibitory balance in the regulation of
the stress response, and (ii) the documented association between
chronic stress exposure with consequent dysfunctional regulation
of the stress response and the subsequent development of psycho-
pathology (Lupien et al., 2009; Franklin et al., 2012). The following
section will review this ﬁeld of research with a speciﬁc emphasis
on the putative pathological and potentially therapeutically rele-
vant roles of GABA and neurosteroids to alter the inhibitory-excit-
atory balance. A detailed review of the glutamatergic hypothesis of
depression is beyond the scope of this review and can be found
elsewhere (see Sanacora et al., 2012; Popoli et al., 2012).
7.1. GABA, neurosteroids and depressive disorders
Findings form clinical and preclinical studies have provided
compelling evidence for an association between alterations in
GABAergic transmission and stress-related psychiatric disorders
including depression (Sanacora et al., 2000; Krystal et al., 2002;
Luscher et al., 2011; Mohler, 2012; Zorumski et al., 2013). Abnor-
mal GABA signalling in major depressive disorders was initially
suggested following studies from the early 1980s that demon-
strated reduced plasma and cerebrospinal ﬂuid (CSF) levels of
GABA in patients suffering from depressive disorders (Gold et al.,
1980; Petty and Schlesser, 1981), an observation subsequently
conﬁrmed by magnetic resonance spectroscopy studies of GABAlevels (Sanacora et al., 1999, 2004; Hasler et al., 2007). Moreover,
a reduction in the density of GABAergic interneurons has been
reported in the cortex and amygdala of depressed patients
(Rajkowska et al., 2007; Maciag et al., 2010; Guilloux et al.,
2012). Post-mortem microarray studies have additionally indi-
cated widespread alterations in the expression of GABAAR subunits
and/or GABAAR-associated binding proteins speciﬁcally in suicide
victims suffering from major depressive disorders (Sequeira et al.,
2009), thus reinforcing the notion of a pathologically relevant asso-
ciation between GABAergic deﬁcits and depression.
Although there are considerable limitations in interpreting
behavioural data from rodent models of psychiatric disorders
(Nestler and Hyman, 2010), evidence emerging from such studies
is nevertheless consistent with a deﬁcit in GABAergic inhibition
in the pathogenesis of depressive-like behaviours. For example,
heterozygous deletion of the c2 GABAAR (c2+/) subunit results
in a brain region-speciﬁc reduction (6–35%) in [3H] ﬂumazenil
binding and receptor clustering, with the most pronounced
changes occurring in limbic and cortical regions (Crestani et al.,
1999). Importantly, this deﬁcit in GABAAR function associates with
increased behavioural responses to aversive stimuli such as nov-
elty, exposed space and brightly illuminated areas, all indicative
of an anxious-like phenotype (Crestani et al., 1999). Recent studies
have revealed that selectively inducing the heterozygous c2 sub-
unit deletion in developing forebrain glutamatergic neurones not
only recapitulates the behavioural deﬁcits associated with the glo-
bal c2+/ (Earnheart et al., 2007), but also results in an increased
basal HPA axis activity (Shen et al., 2010). Although currently not
known, it is tempting to speculate that neurosteroids, the levels
of which are normally elevated during early development (Fig. 4)
may be implicated in the development of these perturbations.
The observation that the development of a hyperactive HPA axis
during the neonatal period associates with an anxious and depres-
sive adult phenotype when a genetically-engineered c2-GABAAR
deﬁcit is introduced embryonically, but not in the fourth postnatal
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cological manipulation of GABAAR function at speciﬁc develop-
mental time points with the BDZ, diazepam, associated with the
development of distinct behavioural phenotypes in adulthood.
Thus, diazepam administration at P10–P16 (but not during subse-
quent weeks) resulted in increased anxiety-like behaviour on the
elevated plus maze (EPM) in adulthood, while the same treatment
selectively between P29-35 resulted in an increased immobility i.e.
a possible surrogate of depressive-like behaviour in the FST in
adulthood (Shen et al., 2012). These observations suggest that
the generation of anxiety- and depressive-like behaviours as mea-
sured in the EPM and FS tests respectively, are highly sensitive to
manipulation of GABAergic inhibition mediated by c2-GABAARs
during distinct critical periods of postnatal development (Shen
et al., 2012). Whether neurosteroids contribute to these pheno-
types is not known but warrants further investigation, particularly
in the light of the role of neurosteroidogenesis in the midazolam
mediated effects in hippocampal function and the documented
agonist activity of diazepam at the TSPO receptor (Tokuda et al.,
2010; McCauley et al., 1992).
Support for 3a-reduced neurosteroids in the pathogenesis of
depressive disorders has derived from preclinical and clinical stud-
ies of the past two decades, which postulated a therapeutically rel-
evant contribution by these endogenous modulators to the
anxiolytic properties of some SSRIs (e.g. ﬂuoxetine – (Guidotti
and Costa, 1998; Eser et al., 2006; Uzunova et al., 2006; Schule
et al., 2014). Thus, the plasma and CSF levels of 5a3a-THPROG
are reduced in depressed patients (Romeo et al., 1998; Uzunova
et al., 1998) and, similarly in animal models of depression, or
post-traumatic stress disorder (PTSD) in a brain region speciﬁc
manner (Serra et al., 2001, 2008; Pinna, 2010). Furthermore, exog-
enous neurosteroid treatment produces antidepressant-like effects
in a rodent model of chronic social isolation (Pibiri et al., 2008;
Pinna, 2010; Evans et al., 2012). Of note and potential clinical rel-
evance, the levels of 3b-reduced neurosteroids e.g. isopregnano-
lone (3b-THPROG), which at relatively high concentrations is a
negative modulator of GABAAR function (Maitra and Reynolds,
1998), appeared increased in chronic fatigue syndrome, a condition
sharing features with depression (Murphy et al., 2004). Similarly, a
chemically-induced panic attack was associated with a pro-
nounced increase in the levels of isopregnanolone in panic disorder
patients, who in absence of panic attacks display decreased levels
of the same neurosteroid relative to a cohort of healthy controls
(Strohle et al., 2002, 2003). Thus, collectively, these ﬁndings sug-
gest a potential contribution of this steroid to the symptomatology
of psychiatric disorders. Interestingly, studies in rodents have addi-
tionally demonstrated that the brain levels of 5a3a-THPROG are
normalised following acute treatment with the SSRI, ﬂuoxetine,
in a stereoselective manner (Uzunov et al., 1996; Matsumoto
et al., 1999; Serra et al., 2001; Pinna et al., 2004). These ﬁndings
have a human correlate as CSF levels of this neurosteroid are
restored in depressed patients following SSRI treatment in a man-
ner which correlates with improved symptomatology (Romeo
et al., 1998; Uzunova et al., 1998). Crucially, ﬂuoxetine increased
the levels of neurosteroids independently of any effect upon sero-
tonin reuptake and on a rapid time scale (i.e. 30 min) that is not
compatible with that associated with the clinical improvements
reported for SSRI treatment (i.e. 3 weeks; Uzunov et al., 1996;
Guidotti and Costa, 1998; Pinna et al., 2004). Such ﬁndings have
thus raised the suggestion that an enhancement of GABAAR-medi-
ated inhibition may contribute to the anxiolytic actions of these
antidepressants (Longone et al., 2008). The mechanism by which
ﬂuoxetine and other SSRIs (e.g. paroxetine) increase the levels of
5a3a-THPROG was initially postulated to involve modulation of
3a-HSD activity (Uzunov et al., 1996; Grifﬁn and Mellon, 1999).
However, a direct interaction between SSRIs and 3a-HSD remainscontroversial as subsequent studies failed to support the initial
ﬁndings (Trauger et al., 2002).
Establishing with conﬁdence whether the increase in neuroster-
oid levels associated with SSRI treatment contributes to the thera-
peutic action of these antidepressants in humans has proved
difﬁcult to assess and remains unclear. Indeed, although various
SSRIs (e.g. ﬂuoxetine, paroxetine) elevate neurosteroid levels and
alleviate depressive symptoms, a number of other pharmacological
and non-pharmacological antidepressant treatments produce
clinical improvements in patients suffering from major depressive
disorders, independently of any effect upon the levels of 5a3a-
THPROG (Padberg et al., 2002; Schule et al., 2003, 2006, 2014;
Baghai et al., 2005). Challenging the clinical signiﬁcance of
increased neurosteroid levels ameliorating depression, 5a3a-
THPROG levels increased in both responders and non-responders,
following treatment with the antidepressant mirtazapine (Schule
et al., 2006). Thus, it remains unclear whether the normalisation
of 5a3a-THPROG levels following ﬂuoxetine treatment is actively
involved in alleviating depressive symptoms, or is simply a phar-
macological by-product associated with clinical beneﬁt. Neverthe-
less, the recent observation that the 18 kDa-translocator protein
(TSPO) is the target of novel anxiolytic drugs (e.g. XBD173), that
stimulate neurosteroidogenesis to produce anxiolytic effects, with-
out the side-effect proﬁle typically associated with classical BDZs
(e.g. sedation, tolerance), suggests that neurosteroids and/or neu-
rosteroidogenic compounds may still offer a promising approach
for the treatment of affective disorders.
7.2. Hippocampal neurogenesis and stress: a role for GABA AR and
neurosteroids and relevance to stress-associated psychopathology and
treatment
Over recent years a relatively novel, but increasingly prevalent
avenue of research aimed at understanding the pathophysiology
of cognitive and major depressive disorders has focused upon the
mechanisms regulating adult hippocampal neurogenesis. Adult
neurogenesis is a complex multistep process that occurs in the
mammalian hippocampus, striatum and olfactory bulb
(Kempermann et al., 2004; Young et al., 2011), and appears, in ani-
mal models, to be particularly sensitive to physiological and envi-
ronmental conditions, including acute or chronic stressor exposure
(Cameron and Gould, 1994; Czeh et al., 2002; Heine et al., 2004;
Oomen et al., 2007).
In this context, the role of GABAAR-mediated signalling in the
proliferation, integration and survival of newborn hippocampal
neurones may be of particular signiﬁcance (Tozuka et al., 2005;
Ge et al., 2006, 2007; Duveau et al., 2011). In common with neo-
nates, newborn neurones in the adult hippocampus undergo a ste-
reotypical integration process, where they initially receive tonic
GABAAR activation followed by the generation of GABAAR-medi-
ated synaptic inputs and ﬁnally glutamate-mediated synaptic
inputs (Ge et al., 2007; Ben-Ari, 2002). Furthermore, electrophysi-
ological analysis has revealed that GABA depolarises immature
neural progenitor cells for the ﬁrst two–three weeks of their neu-
ronal development, an action that is crucial for normal structural
and functional maturation as well as network integration
(Tozuka et al., 2005; Ge et al., 2006). The GABAergic effects on cell
proliferation, initial migration and early dendritic arborisation are
mediated at least in the hippocampus by a4-containing GABAARs,
whilst a2-GABAARs regulate the position of newborn neurones
within the DG and the late maturation of their dendritic processes
(Duveau et al., 2011). Stress in adult rodent models can induce sup-
pression of neurogenesis, which is reversible following the cessa-
tion of stressor exposure or pharmacological treatment (Heine
et al., 2004; Oomen et al., 2007). However, early-life stress-induced
inhibition of neurogenesis appears to persist throughout life
42 B.G. Gunn et al. / Frontiers in Neuroendocrinology 35 (2015) 28–48(Korosi et al., 2012). Thus, various models of prenatal stress exhibit
cognitive and emotional deﬁcits that associate with a long lasting
impairment of hippocampal neurogenesis (Lemaire et al., 2000;
Lucassen et al., 2009; Korosi et al., 2012). Although postnatal stress
produces more variable results, in general similar deﬁcits in hippo-
campal neurogenesis appear to prevail. Importantly, the effect of
early life environment upon adult neurogenesis and the respon-
sivity to novel experiences in adulthood appear to be dependent
upon a number of factors including the age at which neurogenesis
is determined, the frequency of the postnatal stressor (i.e. being
either single or recurrent) and the gender (reviewed in Korosi
et al., 2012; Loi et al., 2014). For example, exposure to a recurrent
maternal separation paradigm during postnatal development
impaired stress-induced plasticity of hippocampal neurogenesis
in adulthood (Mirescu et al., 2004), whilst exposure to a single pro-
longed postnatal (P3) stress resulted in a suppression of adult hip-
pocampal neurogenesis, impaired spatial learning, yet an
enhancement of contextual learning in a stressful environment
(Oomen et al., 2010). Interestingly, evidence from animal and clin-
ical studies lends considerable correlative support to the notion
that new neurones are required in the adult brain for antidepres-
sant efﬁcacy, but their role in the pathogenesis of mood disorders
remains to be fully elucidated (Eisch and Petrik, 2012; Petrik et al.,
2012; Castren and Hen, 2013). Speciﬁcally, the chronic treatment
of rodents with several classes of antidepressants has resulted in
an increase in hippocampal neurogenesis on a time scale consis-
tent with the clinical efﬁcacy of antidepressant treatment in
humans (Malberg et al., 2000). In non-human primates stress also
decreased neurogenesis, an effect prevented by the concomitant
administration of the antidepressant tianeptine (Czeh et al.,
2001). In further support, ablation of hippocampal neurogenesis
using genetic and radiological methods attenuated the neurogenic
and behavioural effects of antidepressant treatment (Santarelli
et al., 2003). However, it should be noted that the therapeutic
actions of certain antidepressant compounds have been reported
to occur in a neurogenesis-independent manner (Surget et al.,
2008; Bessa et al., 2009). Moreover, there is a general consensus
that ablation of hippocampal neurogenesis is not sufﬁcient to
induce a depressive or anxiety-like behaviour in rodents (reviewed
in Petrik et al., 2012). Thus, despite evidence suggesting a role for
new born hippocampal neurones in mediating the efﬁcacy of cer-
tain antidepressant compounds, a clear and coherent model
explaining the mechanisms whereby adult born neurones contrib-
ute to emotional behaviours and/ or to the pathogenesis of depres-
sive disorders remains to be formulated (Eisch and Petrik, 2012;
Kheirbek et al., 2012). Speciﬁcally, further studies are required to
elucidate the relationship between the role of new-born hippo-
campal neurones in the regulation of emotional behaviours and
to determine how stress-induced changes in neurogenesis are rel-
evant to the pathogenesis of depressive disorders.
Nevertheless, because GABA-mediated signalling is an impor-
tant component of adult neurogenesis through a process that
appears largely to recapitulate the neuronal developmental pro-
cesses of embryonic/ neonatal stages, the GABA-modulatory
actions of neurosteroids may be relevant and of possible therapeu-
tic interest. Consistent with this suggestion, 5a3a-THPROG does
exhibit proliferative effects in rat hippocampal, and human cortical
progenitor cells in culture (Wang et al., 2005), raising the prospect
that the regenerative properties of these endogenous neuromodu-
lators may be of therapeutic beneﬁt (Wang et al., 2008). Support
for this proposal is provided by the effects of 5a3a-THPROG upon
hippocampal neurogenesis and cognitive function in a mouse
model of Alzheimer’s disease (3xTgAD). Thus, treatment of 3xTgAD
mice with 5a3a-THPROG dose-dependently normalised abnormal
cell proliferation in the SGZ to levels found in wild type mice and
reversed the hippocampal dependent cognitive deﬁcits (Wanget al., 2010). Importantly, the 5a3a-THPROG-induced survival of
neural progenitors in the 3xTgAD mice correlated strongly with
improved memory performance in these mice, suggesting that
early deﬁcits in neurogenesis may indeed contribute to the cogni-
tive decline associated with Alzheimer’s disease. A similar beneﬁ-
cial effect of neurosteroid treatment upon hippocampal
neurogenesis can therefore be postulated in stress-related pathol-
ogies. In agreement, in a social isolation rodent model of chronic
stress, 5a3a-THPROG treatment either concomitantly, or following
the period of social isolation, prevented the development of
depressive-like behaviours measured by the novelty supressed
feeding (NSF) and the forced swim test (FST) and concomitantly
normalised the stress-induced suppression of hippocampal neuro-
genesis (Evans et al., 2012). Importantly, the antidepressant effects
of 5a3a-THPROG in the FST and NSF paradigms were additionally
accompanied by a normalisation of stress-induced BDNF deﬁcits in
the hippocampus (Evans et al., 2012). Although a clear mechanistic
link remains to be established, evidence for a positive correlative
association between 5a3a-THPROG levels and BDNF mRNA
expression have been reported in a number of stress-related brain
regions including the hippocampus, PFC and amygdala (Pibiri et al.,
2008; Nin et al., 2011). The increase in BDNF following neuroster-
oid treatment is intriguing in the contest of the recently reported
treatment of resistant-type of depression with ketamine (Niciu
et al., 2014). Speciﬁcally, ketamine has been suggested to produce
antidepressant effects by increasing synaptogenesis through com-
plex intracellular signalling cascades, which appear dependent
upon the increased synthesis and release of BDNF (Autry et al.,
2011; Duman and Aghajanian, 2012; Liu et al., 2012; Dwyer and
Duman, 2013; Pilc et al., 2013; Zunszain et al., 2013). Thus, estab-
lishing the relationship between BDNF and level of neurosteroids
such as 5a3a-THPROG, and the potential effects of neurosteroids
upon synaptogenesis in limbic and forebrain regions warrants fur-
ther studies.
8. Concluding remarks
Since the pioneering discovery by Purdy and colleagues that a
mild acute stress induced the de novo synthesis of GABAAR-active
neurosteroids in the rodent brain, converging evidence from the
past two decades has deduced an important role for these modula-
tors of neuronal excitability in the regulation and programming of
the stress response. However, our understanding of the speciﬁc
mechanisms whereby neurosteroids may act to regulate both the
programming of the stress response and some of the adaptations
that ensue after acute as well chronic stress challenges in adult-
hood requires much reﬁnement.
Firstly, our knowledge of the molecular signals that mastermind
the expression of the genes for the synthesis and degradation of
neurosteroids both in health and disease is limited. Furthermore,
the recent report documenting a female-selective association
between SNPs in the aldo–keto reductase 1 (AKRC1) and anxiety
levels (Quast et al., 2014) highlights the potential importance of
gender, further emphasising the importance of focused investiga-
tions in this area.
Secondly, although GABAARs are established as selective molec-
ular targets of the stress-induced pregnane neurosteroids such as
5a,3a-THPROG and 5a,3a-THDOC, in contrast to other GABAAR
modulators e.g. benzodiazepines, a detailed understanding of the
speciﬁc receptor subtypes mediating the constellation of neuros-
teroid behaviours is not known. However, the identiﬁcation of
the molecular determinants for neurosteroid binding at the GABAA-
R and the recent development of mice engineered to express neu-
rosteroid-insensitive GABAAR isoforms should be informative in
this regard (Durkin et al., 2011). A similar approach should uncover
the role speciﬁc receptor isoforms play in mediating the action of
B.G. Gunn et al. / Frontiers in Neuroendocrinology 35 (2015) 28–48 43neurosteroids, both during early programming of the stress
response and in the regulation of neuronal and behavioural adap-
tations to acute and/or chronic stress challenges.
Lastly, epidemiological studies suggest stress-associated psy-
chopathology to exhibit sex-bias and, for example, women are
2–3 times more likely to be affected by mood disorders during
their reproductive years. Indirect evidence, as discussed above
(Section 2.2 and 7: Payne et al., 2009; Brummelte and Galea,
2010), suggest a potential role of neurosteroids in the gender-
selectivity of stress-related psychopathology. Future efforts in the
preclinical arena should therefore be conducted in both female
and male subjects. Although appreciating the caveats associated
with work in animals, such studies are nevertheless likely to prove
invaluable in identifying candidate mechanisms and genes on
which future human clinical research should focus.
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